News
-
TGA safety update
Monday | May 22 2017THE Therapeutic Goods Administration (TGA) has issued a new Medicines Safety Update, with the bulletin detailing potential issues around Viekira PAK, ingenol mebutate and testosterone.
-
Maxigesic EU tick
Monday | May 22 2017AFT Pharmaceuticals has been notified of a decision by the European Medicines Agency to approve its Maxigesic paracetamol-ibuprofen combination analgesic for sale in Austria, Belgium, France, Croatia, Germany, Luxembourg, the Netherlands, Portugal and Spain.
-
Nucala orphan drug
Monday | May 22 2017THE Therapeutic Goods Administration has added Nucala (mepolizumab) to its list of designated orphan drugs.
-
German digital health cooperation
Monday | May 22 2017THE Federal Government has signed a Joint Declaration of Intent on Bilateral Health Cooperation with the German Minister for Health, Hermann Grohe, with Australian Minister for Aged Care Ken Wyatt sealing the deal during the first ever G20 Health Minister's Meeting in Berlin last week.
-
SHPA Constitution revamp
Monday | May 22 2017PHARMACY assistants and technicians will be able to become voting members of the Society of Hospital Pharmacists of Australia (SHPA) as part of a wide-ranging proposed makeover of the organisation's Constitution.
-
FIP urges global cooperation
Monday | May 22 2017THE International Pharmaceutical Federation (FIP) has called on scientists, pharmacy practitioners and educators from across the globe to work together in order to respond to the world's "pressing health care needs".
-
Dispensary Corner 19 May 17
Friday | May 19 2017THERE is a reason why there's beauty in beauty sleep.
-
Amazon pharmacy?
Friday | May 19 2017GLOBAL online retailing giant Amazon is considering a push into the pharmacy market, with the recruitment of a general manager to tap into the "multibillion dollar opportunity" of selling prescription drugs, according to US reports this week which have seen declines in the share prices of CVS and Walgreens Boots Alliance.
-
TGA pulls IntelliVue
Friday | May 19 2017HEALTH professionals are advised that the Therapeutic Goods Administration (TGA) has suspended the licence to supply Philips IntelliVue MX40 wearable patient monitor after identifying a significant increase in reports of incidents where the device's speaker has failed.